KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Taxes (2018 - 2024)

Historic Current Taxes for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q4 2024 value amounting to $176000.0.

  • Adaptive Biotechnologies' Current Taxes rose 19830.51% to $176000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $176000.0, marking a year-over-year increase of 19830.51%. This contributed to the annual value of $176000.0 for FY2024, which is 19830.51% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its Current Taxes stood at $176000.0 for Q4 2024, which was up 19830.51% from $59000.0 recorded in Q4 2023.
  • In the past 5 years, Adaptive Biotechnologies' Current Taxes ranged from a high of $1.8 million in Q4 2020 and a low of $59000.0 during Q4 2023
  • For the 5-year period, Adaptive Biotechnologies' Current Taxes averaged around $517400.0, with its median value being $194000.0 (2022).
  • In the last 5 years, Adaptive Biotechnologies' Current Taxes plummeted by 7787.21% in 2021 and then soared by 19830.51% in 2024.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Current Taxes stood at $1.8 million in 2020, then crashed by 77.87% to $391000.0 in 2021, then plummeted by 50.38% to $194000.0 in 2022, then tumbled by 69.59% to $59000.0 in 2023, then surged by 198.31% to $176000.0 in 2024.
  • Its last three reported values are $176000.0 in Q4 2024, $59000.0 for Q4 2023, and $194000.0 during Q4 2022.